Skip to main content

Tocilizumab Injection

Last Updated: July 29, 2022
Status: Current

Reason for the Shortage
    • Genentech has all Actemra presentations available.
Available Products
    • Actemra intravenous solution for injection, Genentech, 20 mg/mL, 10 mL vial, NDC 50242-0136-01
    • Actemra intravenous solution for injection, Genentech, 20 mg/mL, 20 mL vial, NDC 50242-0137-01
    • Actemra intravenous solution for injection, Genentech, 20 mg/mL, 4 mL vial, NDC 50242-0135-01
    • Actemra subcutaneous solution for injection, Genentech, 162 mg/0.9 mL, prefilled syringe, NDC 50242-0138-01
    • Actemra ACTPen subcutaneous solution for injection, Genentech, 162 mg/0.9 mL, prefilled syringe, NDC 50242-0143-01

Alternative Agents & Management

    • NIH has provided treatment options for hospitalized patients with Covid-19. These can be found at: https://www.covid19treatmentguidelines.nih.gov/management/clinical-management/hospitalized-adults--therapeutic-management/

Updated

Updated July 29, 2022 by Anthony Trovato, PharmD, BCPS. Created August 3, 2021 by Stephen Andrews, PharmD, BCPS, CPPS, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.